Latest News

Infant RSV hospitalization rates 28%, 43% lower this season vs pre-COVID seasons | Image Credit: © MargJohnsonVA - © MargJohnsonVA - stock.adobe.com.
Infant RSV hospitalization rates 28%, 43% lower this season vs pre-COVID seasons

May 9th 2025

"These findings support Advisory Committee on Immunization Practices’ recommendations for maternal vaccination or nirsevimab to protect against severe RSV disease in infants," wrote the MMWR study investigators.

RSV prophylaxis: Palivizumab, nirsevimab, and more | Image Credit: © John Doe - © John Doe - stock.adobe.com.
RSV prophylaxis: Palivizumab, nirsevimab, and more

May 6th 2025

Nirsevimab shows strong real-world effectiveness against RSV in infants | Image credit: © Peter Hansen - stock.adobe.com.
Nirsevimab shows strong real-world effectiveness against RSV in infants

May 1st 2025

Full recap from the 2025 Pediatric Academic Societies meeting |  Image Credit: © SCStock - © SCStock - stock.adobe.com.
Full recap from the 2025 Pediatric Academic Societies meeting

May 1st 2025

Lea Widdice, MD, director, Adolescent Medicine Fellowship; associate professor, University of Cincinnati Department of Pediatrics, Cincinnati, Ohio.
Uncovering the pediatrician's role in OTC STI testing, with Lea Widdice, MD

April 30th 2025

Video Interviews
Podcasts
children on tablet
COVID-19 vaccine

More News

© 2025 MJH Life Sciences

All rights reserved.